Skip to main content

Table 2 Comparison of proteinuria between two groups at different time points

From: The clinical efficacy of fluticasone propionate combined with ACEI/ARB in the treatment of immunoglobulin A nephropathy

Follow-up time (months)

Supportive care group (n = 71, g/d)

Supportive care plus fluticasone group (n = 71, g/d)

p

3

1.9 [1.5, 2.5]

1.2 [0.8, 1.7]

0.001

6

2.0 [1.1, 2.5]

1.0 [0.7, 1.4]

< 0.001

9

1.8 [0.9, 2.6]

0.9 [0.5, 1.0]

0.002